Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Doctors move dementia assessment from paper to smartphone

Evidence-based ACEmobile app soon to be launched

A team of clinicians from Australia and the UK have translated one of the most commonly used dementia screening tools into app form to speed up patient assessment.

The ACEmobile app uses the paper-based Addenbrooke's Cognitive Examination (ACE-III) as its starting point and will be made available free of charge in forms for Apple and Android devices in the next couple of months.

Officially launched today at the Healthcare Innovation Expo 2013 in London, its developers say the app provides a sensitive, reliable, secure and easy-to-administer dementia assessment tool that can be used by a wide range of medical and other healthcare staff.

ACEmobile came out of a collaboration between senior clinicians from Neuroscience Research Australia, Derriford Plymouth Hospitals NHS Trust and Plymouth University Peninsula Schools of Medicine and Dentistry.

One of the team, Derriford's Dr Rupert Noad, said: “ACE-III is a great assessment tool, but as with many such tools which are paper-based, it has been open to human error and miscalculation.

“By producing the ACEmobile app we have reduced the risk of such error and miscalculation and created a tool which can be used by the wider dementia care team. Dementia is applying increasing pressure on health care services around the world and is set to continue to do so – by creating a reliable, accurate and easy to use application of ACE-III, and making it free of charge, we hope that the future of the ACEmobile project can play a role in earlier and more accurate diagnoses.”

ACEmobile has been designed to ensure that the assessment is effortless to administer. The administration instructions are embedded within the app, which means that the clinical team no longer need to refer to a manual. This means it is much easier to accurately and reliably deliver the assessment with patients.

The ACEmobile team have the aspiration that the app will also be a valuable tool for research, resulting in the development of better normative data for different patient populations and ACE-III individual sub-test norms.

13th March 2013

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...